Clinical Trials in Pittsburgh

Showing 14381-14400 of 21,047 trials

Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma

NCT01608594

The purpose of this study is to evaluate the safety and potential effectiveness of a new treatment for advanced and recurrent melanoma involving the combination of Ipilimumab and IFN-α2b before surgery and to test for biomarker studies in blood and/or tumor to better understand this disease, how best to treat it and what patients should be treated with this combination.

Melanoma

Diwakar Davar30 participantsStarted May 2013

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

NCT00289783

This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT vaccine lots and the safety and immunogenicity of Hib-MenCY-TT vaccine compared to a control group receiving licensed Hib conjugate vaccine, when each are co-administered with Pediarix® to healthy infants at 2, 4, and 6 months of age. The study will also evaluate the safety and immunogenicity of Hib-MenCY-TT vaccine compared to a control group receiving licensed Hib conjugate vaccine, when each are co-administered with M-M-R® II and Varivax® at 12 to 15 months of age.

Haemophilus Influenzae Type bNeisseria Meningitidis

GlaxoSmithKline4,441 participantsStarted Feb 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +90 more locations

Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Find Trials by Condition in Pittsburgh

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

Use of dHACM in the Treatment of Venous Leg Ulcers

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier

Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)

Caring Letters for Military Suicide Prevention

The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea

Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Intermittent Auscultation Using Handheld Doppler: a Randomized Controlled Trial Comparing Perinatal Outcomes in Uganda

Building Capacity for Sustainable Livelihoods and Health

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms

The Effects of Extraoral Photobiomodulation on the Rate of Orthodontic Alignment

VIveve Treatment of the Vaginal Introitus to EValuate Effectiveness

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss